Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRIFLOW: Trimbow vs Fostair in COPD
NCT03842904Phase 4Completed
- Sponsor
- Medicines Evaluation Unit
- Start
- Dec 2018
- Primary completion
- Jul 2019
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of beclometasone dipropionate/formoterol fumarate/glycopyrronium in chronic obstructive pulmonary disease (COPD), sponsored by Medicines Evaluation Unit. Started Dec 2018; status: completed.
02
Drugs
beclometasone dipropionate/formoterol fumarate/glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT03842904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03842904.